히알루론산 시장 규모, 점유율, 동향 분석 보고서 : 용도별, 지역별, 부문별 예측(2025-2030년)

Hyaluronic Acid Market Size, Share & Trends Analysis Report By Application (Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,176,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,550,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,299,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

히알루론산 시장 성장과 동향:

Grand View Research, Inc.의 새로운 보고서에 따르면, 세계 히알루론산 시장 규모는 2025년부터 2030년까지 7.81%의 CAGR을 기록하며 2030년까지 167억 달러에 달할 것으로 예상됩니다.

화학제품에 대한 사람들의 관심 증가, 빠르고 확실한 결과를 얻고자 하는 욕구, 회복 시간 단축 등의 요인은 영향력 있는 렌더링 촉진요인입니다. 산업은 선진국과 개발도상국에서 미용 시술의 채택이 증가함에 따라 빠르게 발전하고 있습니다. 스텐트 및 인공 혈관과 같은 심혈관 임플란트에서 히알루론산 표면의 사용은 노화 방지 제품에 대한 인식의 증가와 함께 적합성을 향상시키기 위해 증가하고 있으며, 이는 성장을 촉진하고 있습니다.

히알루론산 기반 피부 필러의 효과와 명백한 결과가 이 인구 기반을 끌어들이고 있습니다. 또한, COVID-19는 많은 산업의 역학을 바꾸어 이동 제한, 사회적 거리두기, 관행의 재검토가 "새로운 상식"이 되었습니다. 화장품 업계가 서서히 영업을 재개하면서 많은 의사들이 성형수술 문의가 크게 증가했다고 보고하고 있습니다. 또한 봉쇄로 인해 각 전문가들이 화상 회의 시설을 이용하게 되면서 사람들은 자신의 외모를 더욱 의식하게 되었습니다. 경우에 따라 사람들은 미용 시술을 선택하기도 합니다. 이를 "줌 붐" 또는 "줌 효과"라고 부릅니다.

전 세계 성형외과 의사들은 특히 미국, 호주, 일본과 같은 국가에서 팬데믹으로 인해 환자 수가 크게 증가한 것을 목격하고 있습니다. 북미는 2022년에 가장 큰 매출 점유율을 차지했습니다. 높은 가격에도 불구하고 단기 치료 요법에 대한 선호와 골관절염과 같은 대상 질환의 유행이 높은 점유율의 주요 요인이며, 2022년 북미에서 가장 유리한 제품 용도는 골관절염 관리를 위한 피부 필러와 비스코스 보충제 형태였습니다. 아시아태평양은 예측 기간 동안 가장 빠른 CAGR을 기록할 것으로 예상됩니다.

중국과 일본은 노령인구가 증가하면서 노화방지 제품 및 서비스의 대규모 고객층이 되고 있습니다. 제품의 용도와 효능에 대한 인식이 높아짐에 따라 수요가 증가하고 있습니다. 또한, 가처분 소득 수준의 상승은 이 지역의 성장을 더욱 촉진하고 있습니다. 유럽은 지난 2년 동안 괄목할 만한 변화를 겪었습니다. 수요 증가로 인해 신규 진입 업체들의 가격 경쟁이 심화되고 있으며, WHO는 최근 영국과 독일에서 비만율이 급증하고 있다고 발표했습니다. 고령화 인구의 증가와 비만의 관계는 유럽 지역 부문의 잠재적 원동력입니다.

히알루론산 시장 보고서 하이라이트

• 피부 필러 부문이 시장을 장악하고 2024년 41.82%의 최대 매출 점유율을 차지했습니다.
• 북미는 2024년 42.08%의 점유율을 차지하며 시장을 지배했습니다. 히알루론산 시장은 노화 방지 치료에 대한 수요 증가, 골관절염 환자 증가, 최소침습 수술에 대한 인식 증가에 의해 주도되고 있습니다.
• 미국 히알루론산 시장은 비수술적 미용 시술에 대한 수요 증가와 의료 응용, 특히 히알루론산 기반 피부 필러의 발전에 힘입어 강력한 성장세를 보이고 있습니다.
• APAC 히알루론산 시장은 예측 기간 동안 8.25%의 CAGR로 성장할 것으로 예상됩니다. .

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 히알루론산 시장 변수, 동향, 범위

• 시장 계통 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 비즈니스 환경 분석
  • 업계 분석 - Porter's Five Forces 분석
  • PESTEL 분석
  • 파이프라인 분석
  • 특허 만료 분석
  • 가격 분석

제4장 히알루론산 시장 : 용도 추정·동향 분석

• 용도별 시장 점유율, 2024년 및 2030년
• 용도별 부문 대시보드
• 시장 규모, 예측, 동향 분석(용도별, 2018-2030년)
  • 피부 충전제
  • 골관절염
  • 안과
  • 방광요관역류증

제5장 히알루론산 시장 : 지역 추정·동향 분석

• 지역별 시장 점유율 분석, 2024년 및 2030년
• 지역별 시장 대시보드
• 시장 규모, 예측 동향 분석, 2018년부터 2030년까지 :
• 북미
  • 국가별, 2018-2030년
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제6장 경쟁 구도

• 참여자 개요
• 기업의 시장 포지션 분석
• 기업 분류
• 전략 매핑
• 기업 개요/리스트
  • Allergan
  • Sanofi
  • Genzyme Corporation
  • Anika Therapeutics, Inc.
  • Salix Pharmaceuticals
  • Seikagaku Corporation
  • F. Hoffmann-La Roche Ag
  • Galderma Laboratories LP
  • Zimmer Biomet
  • Smith &Nephew Plc
  • Ferring BV
  • Lifecore Biomedical, Llc
  • HTL Biotechnology
  • Shiseido Company, Limited
  • Bloomage Biotechnology Corporation Limited
  • LG Life Sciences Ltd(LG Chem.)
  • Maruha Nichiro, Inc.

ksm

영문 목차

영문목차

Hyaluronic Acid Market Growth & Trends:

The global hyaluronic acid market size is expected to reach USD 16.7 billion by 2030, registering a CAGR of 7.81% from 2025 to 2030, according to a new report by Grand View Research, Inc. Factors, such as increasing concern of population regarding chemicals, desire to get quick and evident results, and shorter recovery time are high impact rendering drivers. The industry is evolving rapidly due to the increasing adoption of aesthetic procedures in developed and developing regions. Increasing the use of hyaluronic acid surfaces in cardiovascular implants, such as stents and vascular grafts, for improving compatibility coupled with the growing awareness about anti-aging products is fueling the growth.

The efficacy and evident results of hyaluronic acid-based dermal fillers are attracting this population base. Furthermore, the COVID-19 pandemic has changed the dynamics of many industries, with movement restrictions, social distancing, and revised practices becoming the "new normal." As the cosmetic industry is gradually resuming its operations, a number of doctors have reported a significant increase in inquiries for aesthetic surgeries. Moreover, the lockdown has encouraged all professionals to use video-conferencing facilities, which has made people more conscious of their looks. In some cases, it has led people to opt for cosmetic treatments; this is termed the "Zoom Boom" or the "Zoom effect."

Cosmetic surgeons across the world have witnessed a significant increase in the number of patients as a result of the pandemic, particularly in countries, such as the U.S., Australia, and Japan. North America held the maximum revenue share in 2022. Preference for short-treatment regimens, even though high-priced, and the prevalence of target diseases, such as osteoarthritis, are the key factors attributed to the high share. In 2022, the most lucrative product applications in the North America region were in the form of dermal fillers and viscos supplements for the management of osteoarthritis. Asia Pacific is anticipated to register the fastest CAGR during the forecast period.

The growing geriatric population in China and Japan provide a large customer base for anti-aging products and services. Rising awareness about product applications and efficacy also fuels the demand. In addition, increasing disposable income levels are further supporting the region's expansion. Europe has undergone impressive changes over the last 2 years. The growing demand is witnessing increasing price competition owing to new entrants. The WHO recently announced the obesity epidemic in the U.K. and Germany. The relationship between the increasing aging population and obesity is a potential driver for the Europe regional sector

Hyaluronic Acid Market Report Highlights:

• The dermal fillers segment dominated the market and obtained the largest revenue share of 41.82% in 2024.
• North America dominated the market and accounted for 42.08% share in 2024. The hyaluronic acid market is driven by increasing demand for anti-aging treatments, rising osteoarthritis cases, and growing awareness of minimally invasive procedures.
• The U.S. hyaluronic acid market is experiencing robust growth, driven by increasing demand for non-surgical aesthetic procedures and advancements in medical applications, particularly hyaluronic acid-based dermal fillers.
• APAC hyaluronic acid market is anticipated grow with a CAGR of 8.25% over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Application
  • 1.2.2. Regional scope
  • 1.2.3. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
• 1.8. List of Secondary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Hyaluronic Acid Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrant
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTEL Analysis
  • 3.3.3. Pipeline Analysis
  • 3.3.4. Patent Expiry Analysis
  • 3.3.5. Pricing Analysis

Chapter 4. Hyaluronic Acid Market: Application Estimates & Trend Analysis

• 4.1. Application Market Share, 2024 & 2030
• 4.2. Application Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analyses, By Application, 2018 to 2030
  • 4.3.1. Dermal fillers
    • 4.3.1.1. Dermal fillers Market 2018 - 2030 (USD Million)
  • 4.3.2. Osteoarthritis
    • 4.3.2.1. Osteoarthritis Market 2018 to 2030 (USD Million)
    • 4.3.2.2. Single-injection
      • 4.4.2.2.1 Single injection Market 2018 to 2030 (USD Million)
    • 4.3.2.3. Three-injection
      • 4.4.2.3.1. Three injection Market 2018 to 2030 (USD Million)
    • 4.3.2.4. Five-injection
      • 4.4.2.3.1. Five injection Market 2018 to 2030 (USD Million)
  • 4.4.3. Ophthalmic
    • 4.4.3.3. Ophthalmic Market 2018 to 2030 (USD Million)
  • 4.4.4. Vesicoureteral reflux
    • 4.4.2.3. Vesicoureteral reflux Market 2018 to 2030 (USD Million)

Chapter 5. Hyaluronic Acid Market: Regional Estimates & Trend Analysis

• 5.1. Regional Market Share Analysis, 2024 & 2030
• 5.2. Regional Market Dashboard
• 5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 5.4. North America
  • 5.5.1. North America Hyaluronic Acid Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 5.5.2. U.S.
    • 5.5.1.1. Key country dynamics
    • 5.5.1.2. Regulatory framework/
    • 5.5.1.3. Reimbursement structure
    • 5.5.1.4. U.S. Hyaluronic Acid market 2018 to 2030 (USD Million)
  • 5.5.3. Canada
    • 5.5.1.1. Key country dynamics
    • 5.5.1.2. Regulatory framework
    • 5.5.1.3. Reimbursement structure
    • 5.5.1.4. Canada Hyaluronic Acid market 2018 to 2030 (USD Million)
  • 5.5.4. Mexico
    • 5.5.1.1. Key country dynamics
    • 5.5.1.2. Regulatory framework
    • 5.5.1.3. Reimbursement structure
    • 5.5.1.4. Mexico Hyaluronic Acid market 2018 to 2030 (USD Million)
• 5.5. Europe
  • 5.5.1. Europe Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.2. UK
    • 5.5.2.1. Key Country Dynamics
    • 5.5.2.2. Regulatory Framework
    • 5.5.2.3. Reimbursement Framework
    • 5.5.2.4. UK Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.3. Germany
    • 5.5.3.1. Key Country Dynamics
    • 5.5.3.2. Regulatory Framework
    • 5.5.3.3. Reimbursement Framework
    • 5.5.3.4. Germany Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.4. France
    • 5.5.4.1. Key Country Dynamics
    • 5.5.4.2. Regulatory Framework
    • 5.5.4.3. Reimbursement Framework
    • 5.5.4.4. France Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.5. Italy
    • 5.5.5.1. Key Country Dynamics
    • 5.5.5.2. Regulatory Framework
    • 5.5.5.3. Reimbursement Framework
    • 5.5.5.4. Italy Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.6. Spain
    • 5.5.6.1. Key Country Dynamics
    • 5.5.6.2. Regulatory Framework
    • 5.5.6.3. Reimbursement Framework
    • 5.5.6.4. Spain Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.7. Denmark
    • 5.5.7.1. Key Country Dynamics
    • 5.5.7.2. Regulatory Framework
    • 5.5.7.3. Reimbursement Framework
    • 5.5.7.4. Denmark Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.8. Sweden
    • 5.5.8.1. Key Country Dynamics
    • 5.5.8.2. Regulatory Framework
    • 5.5.8.3. Reimbursement Framework
    • 5.5.8.4. Sweden Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.9. Norway
    • 5.5.9.1. Key Country Dynamics
    • 5.5.9.2. Regulatory Framework
    • 5.5.9.3. Reimbursement Framework
    • 5.5.9.4. Norway Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Asia Pacific
  • 5.6.1. Asia Pacific Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.2. Japan
    • 5.6.2.1. Key Country Dynamics
    • 5.6.2.2. Regulatory Framework
    • 5.6.2.3. Reimbursement Framework
    • 5.6.2.4. Japan Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.3. China
    • 5.6.3.1. Key Country Dynamics
    • 5.6.3.2. Regulatory Framework
    • 5.6.3.3. Reimbursement Framework
    • 5.6.3.4. China Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.4. India
    • 5.6.4.1. Key Country Dynamics
    • 5.6.4.2. Regulatory Framework
    • 5.6.4.3. Reimbursement Framework
    • 5.6.4.4. India Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.5. Australia
    • 5.6.5.1. Key Country Dynamics
    • 5.6.5.2. Regulatory Framework
    • 5.6.5.3. Reimbursement Framework
    • 5.6.5.4. Australia Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.6. South Korea
    • 5.6.6.1. Key Country Dynamics
    • 5.6.6.2. Regulatory Framework
    • 5.6.6.3. Reimbursement Framework
    • 5.6.6.4. South Korea Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.7. Thailand
    • 5.6.7.1. Key Country Dynamics
    • 5.6.7.2. Regulatory Framework
    • 5.6.7.3. Reimbursement Framework
    • 5.6.7.4. Thailand Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Latin America
  • 5.7.1. Latin America Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7.2. Brazil
    • 5.7.2.1. Key Country Dynamics
    • 5.7.2.2. Regulatory Framework
    • 5.7.2.3. Reimbursement Framework
    • 5.7.2.4. Japan Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7.3. Argentina
    • 5.7.3.1. Key Country Dynamics
    • 5.7.3.2. Regulatory Framework
    • 5.7.3.3. Reimbursement Framework
    • 5.7.3.4. China Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Middle East and Africa
  • 5.8.1. Middle East and Africa Hyaluronic Acid Market Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 5.8.2. South Africa
    • 5.8.2.1. Key Country Dynamics
    • 5.8.2.2. Regulatory Framework
    • 5.8.2.3. Reimbursement Framework
    • 5.8.2.4. South Africa Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8.3. Saudi Arabia
    • 5.8.3.1. Key Country Dynamics
    • 5.8.3.2. Regulatory Framework
    • 5.8.3.3. Reimbursement Framework
    • 5.8.3.4. Saudi Arabia Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8.4. UAE
    • 5.8.4.1. Key Country Dynamics
    • 5.8.4.2. Regulatory Framework
    • 5.8.4.3. Reimbursement Framework
    • 5.8.4.4. UAE Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8.5. Kuwait
    • 5.8.5.1. Key Country Dynamics
    • 5.8.5.2. Regulatory Framework
    • 5.8.5.3. Reimbursement Framework
    • 5.8.5.4. Kuwait Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Participant Overview
• 6.2. Company Market Position Analysis
• 6.3. Company Categorization
• 6.4. Strategy Mapping
• 6.5. Company Profiles/Listings
  • 6.5.1. Allergan
    • 6.5.1.1. Company overview
    • 6.5.1.2. Financial performance
    • 6.5.1.3. Product benchmarking
    • 6.5.1.4. Strategic initiatives
  • 6.5.2. Sanofi
    • 6.5.2.1. Company overview
    • 6.5.2.2. Financial performance
    • 6.5.2.3. Product benchmarking
    • 6.5.2.4. Strategic initiatives
  • 6.5.3. Genzyme Corporation
    • 6.5.3.1. Company overview
    • 6.5.3.2. Financial performance
    • 6.5.3.3. Product benchmarking
    • 6.5.3.4. Strategic initiatives
  • 6.5.4. Anika Therapeutics, Inc.
    • 6.5.4.1. Company overview
    • 6.5.4.2. Financial performance
    • 6.5.4.3. Product benchmarking
    • 6.5.4.4. Strategic initiatives
  • 6.5.5. Salix Pharmaceuticals
    • 6.5.5.1. Company overview
    • 6.5.5.2. Financial performance
    • 6.5.5.3. Product benchmarking
    • 6.5.5.4. Strategic initiatives
  • 6.5.6. Seikagaku Corporation
    • 6.5.6.1. Company overview
    • 6.5.6.2. Financial performance
    • 6.5.6.3. Product benchmarking
    • 6.5.6.4. Strategic initiatives
  • 6.5.7. F. Hoffmann-La Roche Ag
    • 6.5.7.1. Company overview
    • 6.5.7.2. Financial performance
    • 6.5.7.3. Product benchmarking
    • 6.5.7.4. Strategic initiatives
  • 6.5.8. Galderma Laboratories L.P.
    • 6.5.8.1. Company overview
    • 6.5.8.2. Financial performance
    • 6.5.8.3. Product benchmarking
    • 6.5.8.4. Strategic initiatives
  • 6.5.9. Zimmer Biomet
    • 6.5.9.1. Company overview
    • 6.5.9.2. Financial performance
    • 6.5.9.3. Product benchmarking
    • 6.5.9.4. Strategic initiatives
  • 6.5.10. Smith & Nephew Plc
    • 6.5.10.1. Company overview
    • 6.5.10.2. Financial performance
    • 6.5.10.3. Product benchmarking
    • 6.5.10.4. Strategic initiatives
  • 6.5.11. Ferring B.V.
    • 6.5.11.1. Company overview
    • 6.5.11.2. Financial performance
    • 6.5.11.3. Product benchmarking
    • 6.5.11.4. Strategic initiatives
  • 6.5.12. Lifecore Biomedical, Llc
    • 6.5.12.1. Company overview
    • 6.5.12.2. Financial performance
    • 6.5.12.3. Product benchmarking
    • 6.5.12.4. Strategic initiatives
  • 6.5.13. HTL Biotechnology
    • 6.5.13.1. Company overview
    • 6.5.13.2. Financial performance
    • 6.5.13.3. Product benchmarking
    • 6.5.13.4. Strategic initiatives
  • 6.5.14. Shiseido Company, Limited
    • 6.5.14.1. Company overview
    • 6.5.14.2. Financial performance
    • 6.5.14.3. Product benchmarking
    • 6.5.14.4. Strategic initiatives
  • 6.5.15. Bloomage Biotechnology Corporation Limited
    • 6.5.15.1. Company overview
    • 6.5.15.2. Financial performance
    • 6.5.15.3. Product benchmarking
    • 6.5.15.4. Strategic initiatives
  • 6.5.16. LG Life Sciences Ltd (LG Chem.)
    • 6.5.16.1. Company overview
    • 6.5.16.2. Financial performance
    • 6.5.16.3. Product benchmarking
    • 6.5.16.4. Strategic initiatives
  • 6.5.17. Maruha Nichiro, Inc.
    • 6.5.17.1. Company overview
    • 6.5.17.2. Financial performance
    • 6.5.17.3. Product benchmarking
    • 6.5.17.4. Strategic initiatives

관련자료